Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
2016 (subcutaneous injection technique)
Generics company Teva Pharmaceutical has obtained approval from the US Food and Drug Administration (FDA) for its generic referencing Novo Nordisk's previous generation of injectable weight loss drug, Saxenda (liraglutide)
Improved glycaemic control may reduce glycosuria (glucose loss in urine), leading to better nutrient retention and modest weight increase in some individuals, particularly early in treatment
IARC Monogr
Certain genetic variants influence how quickly your body reabsorbs bruises and your overall response to injectable therapy, allowing your provider to personalize your injection protocol and aftercare strategy
Real prescriptions written by licensed clinicians, filled by a pharmacy, shipped to you
US$ 28.47
US$ 29.42
US$ 21.57
US$ 21.96
US$ 22.74
US$ 22.26
US$ 22.67
US$ 29.63
